Company Annexin Pharmaceuticals AB (publ) Nasdaq Stockholm
Equities
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anna Frostegård
FOU | Founder | 51 | 31/12/13 |
Chief Executive Officer | 63 | 31/12/17 | |
Director of Finance/CFO | 53 | 10/04/23 | |
Susan Suchdev
COO | Chief Operating Officer | 52 | - |
Alain Thibault
PRN | Corporate Officer/Principal | - | 17/01/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 31/12/20 |
Mårten Österlund
BRD | Director/Board Member | 67 | 31/12/20 |
Chief Executive Officer | 63 | 31/12/17 | |
Director/Board Member | 48 | 31/12/16 | |
Director/Board Member | 65 | 31/12/15 | |
Director/Board Member | 66 | 31/12/16 | |
Director/Board Member | 71 | - | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 31/12/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 526,807,199 | 75,900,956 ( 14.41 %) | 0 | 14.41 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+8.29% | 114B | |
+10.21% | 104B | |
+0.64% | 22.28B | |
-11.90% | 22.41B | |
-5.38% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |